Dynamic List Information
Dynamic List Data
Study Title
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Subjects With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With Gemcitabine or Gemcitabine+Nab-paclitaxel Chemotherapies
Sponsor Name
OncoSil Medical Limited
NCT Number
NCT03076216
IDE Number
G150271
CMS Approval Date
2017-08-17
Clinical Trial Link
Category
B